Results 241 to 250 of about 17,938 (260)
Some of the next articles are maybe not open access.

c-Abl activates RIPK3 signaling in Gaucher disease

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
Gaucher disease (GD) is caused by homozygous mutations in the GBA1 gene, which encodes the lysosomal β-glucosidase (GBA) enzyme. GD affects several organs and tissues, including the brain in certain variants of the disease. Heterozygous GBA1 variants are a major genetic risk factor for developing Parkinson's disease.
Yañez Henríquez, María José   +6 more
openaire   +3 more sources

Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs

Trends in Pharmacological Sciences, 2020
The scaffolding function of receptor-interacting protein kinase 1 (RIPK1) regulates prosurvival signaling and inflammatory gene expression, while its kinase activity mediates both apoptosis and necroptosis; the latter involving RIPK3 kinase activity.
Martens, Sofie   +4 more
openaire   +3 more sources

RIPK3 as a potential therapeutic target for Gaucher's disease

Nature Medicine, 2014
Gaucher's disease (GD), an inherited metabolic disorder caused by mutations in the glucocerebrosidase gene (GBA), is the most common lysosomal storage disease. Heterozygous mutations in GBA are a major risk factor for Parkinson's disease. GD is divided into three clinical subtypes based on the absence (type 1) or presence (types 2 and 3) of ...
Einat B, Vitner   +8 more
openaire   +2 more sources

Detection of Necroptosis by Phospho-RIPK3 Immunohistochemical Labeling

2018
Activation of the kinase RIPK3 (receptor interacting protein kinase 3) is a hallmark of cells dying by necroptosis. RIPK3 phosphorylates both itself and the pseudokinase MLKL (mixed lineage kinase-like) resulting in MLKL translocation to membranes and cell lysis.
Joshua D, Webster   +3 more
openaire   +2 more sources

RIPK1 and RIPK3 form mosaic necrosomes

Nature Cell Biology, 2022
Weiwei Qi, Junying Yuan
openaire   +2 more sources

Home - About - Disclaimer - Privacy